← All candidates
46 insider filings on record.
46 filings on record.
CDXSCODEXIS, INC.
NasdaqGS · Healthcare · $160.43M
$1.47
-5.41% · Sep 15
46 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 25 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$160.43M
Float
82.3M
75% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
2.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Opaleye Management Inc.
Bought $5.48M on May 23 — 2,320,000 sh @ $2.36, held indirect, 19% of their stake.
2 of 5 positions beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
41 more transactions on Pro →Context
Wall St
$6.58 avg target
+347.8% vs today · 6 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$0.10 act+$0.00
Q4 '25$0.14 act+$0.18
Q3 '25−$0.22 act−$0.09
Q2 '25−$0.16 act−$0.01
Coverage
Earnings Release: Here's Why Analysts Cut Their Codexis, Inc. (NASDAQ:CDXS) Price Target To US$6.58Simply Wall St. · 05-11Codexis (CDXS) Q1 2026 Earnings TranscriptMotley Fool · 05-08Codexis, Inc. Q1 2026 Earnings Call SummaryMoby · 05-08Codexis (CDXS) Reports Q1 Loss, Beats Revenue EstimatesZacks · 05-07
The file stays open
46 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice